Vascular and excretory effects of angiotensin II in the rat isolated perfused kidney: Influence of an AT1 and a nonselective AT receptor antagonist

Pharmacology

Volumn 57, Issue 4, 1998, Pages 196-205

  Hilchey, Sean ^a   Quilley, John ^a,b   Bell Quilley, Caroline ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Angiotensin II; Penal functional effects; Perfused rat kidney; Receptor antagonists

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BUFFER; LOSARTAN; RECEPTOR SUBTYPE; SODIUM ION;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIURESIS; GLOMERULUS FILTRATION RATE; ISOLATED KIDNEY; KIDNEY BLOOD FLOW; KIDNEY PERFUSION; KIDNEY VASCULAR RESISTANCE; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; URINARY EXCRETION; URINE VOLUME;

6-KETOPROSTAGLANDIN F1 ALPHA; ANGIOTENSIN II; ANIMALS; DINOPROSTONE; FEMALE; GLOMERULAR FILTRATION RATE; KIDNEY; LOSARTAN; MALE; PERFUSION; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; SODIUM; URINE; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 0031716408     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028242     Document Type: Article

References (17)

1. Navar LG, Langford HG: Effects of angiotensin in the renal circulation; in Page IH, Bumpus FM (eds): Angiotensin. New York, Springer, 1974,pp 455-474.
2. Douglas JG, Hopfer U: Novel aspect of angiotensin receptors and signal transduction in the kidney. Annu Rev Physiol 1994;56:649-669.
3. Peters G, Bonjour JP: Renal effects of renin and angiotensin; in Rouiller C, Muller AF (eds): The Kidney. New York, Academic Press, 1971; vol 4,pp 81-154.
4. Bumpus FM, Catt KJ, Chiu AT, De Gasparo M, Goodfriend T, Husain A, Peach MJ, Taylor DGJ, Timmermans PBMWM: Nomenclature for angiotensin receptors: A report of the nomenclature committee of the council for high blood pressure research. Hypertension 1991;17:720-721.
5. de Gasparo M, Husain A, Alexander W, Catt KJ, Chiu AT, Drew M, Goodfriend T, Harding JW, Inagami T, Timmermans PBMWM: Proposed update of angiotensin receptor nomenclature. Hypertension 1995;25:924-927.
6. Dudley DT, Panek PL, Major TC, Lu GH, Bruns RF, Klinkefus BA, Hodges JC, Weishaar RE: Subclasses of angiotensin binding sites and their functional significance. Mol Pharmacol 1990;38:370-377.
7. Quilley CP, McGiff JC: Isomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid reduce renin activity and increase water and electrolyte excretion. J Pharmacol Exp Ther 1990; 254:774-780.
8. Pradelles P, Grassi J, MacLouf J: Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: An alternative to radioimmunoassay. Anal Chem 1985;57:1170-1173.
9. Schuster VL, Kokko JP, Jacobson HR: Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules. J Clin Invest 1984;73:507-515.
10. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JM, Smith RD: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45:205-251.
11. Campagnole-Santos MJ, Santos RAS, Diz DI, Khosla MC, Ferrario CM: Cardiovascular actions of angiotensin-(1-7) microinjected into the dorsal medial medulla. Am J Physiol 1989;257:H324-H329.
12. Wright JW, Jensen LL, Roberts KA, Sardinia MF, Harding JW: Structure-function analysis of brain angiotensin control of pressor action in rats. Am J Physiol 1989;257: R1551-R1557.
13. Shridar NI, Chappell MC, Averill DB, Diz DI, Ferrario CM: Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension 1998;31:699-705.
14. Dellipizzi AM, Hilchey SD, Bell-Quilley CP: Natriuretic action of angiotensin(1-7). Br J Pharmacol 1994;111:1-3.
15. Tallant EA, Lu X, Weiss RB, Chappell MC, Ferrario CM: Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension 1997;29:388-392.
16. Porsti I, Bara AT, Busse R, Hecker M: Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: Implications for a novel angiotensin receptor. Br J Pharmacol 1994;111:652-654.
17. Parekh N, Dobrowolski L, Zou AP, Steinhausen M: Nitric oxide modulates angiotensin II- and norepinephrine-dependent vasoconstriction in rat kidney. Am J Physiol 1996;270:R630-R635.